As the saying goes: "intestinal disease, half life", once you have ulcerative colitis, it is easy to fall into the vicious circle of "effective medication, recurrence after stopping medication, long-term treatment, and more serious treatment", often endure "abdominal pain, stool mucus and bloody stool, loose stool, increased stool" and other pains, but also worry about cancer, regularly go to the hospital for colonoscopy screening, seriously affect the quality of life of patients.
Some doctors simply tell patients that the cause of ulcerative colitis is not clear, it is difficult to cure it clinically, and in order to avoid aggravation of the disease and cancer, it is usually necessary to take medicine for life to control it, which causes huge mental pressure to patients. Today, with the highly developed medical technology, cancer has been cured, why does ulcerative colitis continue to be cured?
This is because the colon is a very special organ, it is a channel for fecal formation and excretion, storing dirt and dirt, containing a large number of bacteria, viruses, parasites, pathogens, protozoa and other microorganisms. A large number of beneficial bacteria also form a protective film on the surface of the intestinal mucosa, which is called "bacterial membrane barrier" in medicine, which plays a triple protective role of "chemical barrier, biological barrier and immune barrier" on the intestinal mucosa, and healthy people are not allowed to suffer from intestinal diseases.
Once you have enteritis, it means that the healthy balance of the microecology is broken, harmful bacteria have the upper hand, beneficial bacteria have the upper hand, neutral bacteria also see the wind to make the rudder bad, the bacterial membrane barrier disappears, the inflammatory surface of the colonic mucosa is directly exposed to the intestine, and it is swallowed by harmful microorganisms, stimulated by toxins and chemicals, and friction of feces every day.
Due to the unclear cause of ulcerative colitis, the traditional drug treatment is mainly anti-inflammatory, controlling inflammatory reactions, relieving painful symptoms such as fecal mucus and bloody stool, abdominal pain, diarrhea, tenesmus, etc., but it does not improve the structure of intestinal flora from the root, restore the microecological balance and bacterial film barrier, once the drug is stopped, it loses the protection of beneficial bacteria and bacterial film barrier, and after a period of time, harmful bacteria are easy to make a comeback, recur as before, and have to take medicine again.
It is a medicine that is poisonous, and taking medicine for a long time is tantamount to chronic suicide, can we only sit and wait for death?
No, never, while the drug is treating ulcers, supplementing probiotics is expected to make up for the shortcomings of the drug alone and achieve the effect of clinical cure. Therefore, many doctors prescribe anti-inflammatory drugs such as mesalazine to ulcer patients, and also prescribe probiotics such as Bifidobacterium Triple Viable Powder, Clostridium butyricum Live Bacteria, Bacillus cereus, Clostridium butyricum Enterococci Triple Viable Tablets and other drug standard names. Because most of these probiotics are approved before 2006, the formula strain is single, the function of the strain is single, the activity and content of the strain are very low, and the improvement of the intestinal flora structure of the ulcer is like a drop in the bucket, and it is difficult to achieve the effect of clinical cure.
Now, the mainland has a patented strain formula for improving ulcerative colitis Raw Powder Probiotic "Huojun No. 1"
According to the patent details published by the Patent Office of the State Intellectual Property Office: Huojun No. 1 star patented strain Lactobacillus reuteri JYLB-291 can effectively tolerate gastric acid and bile salts, and colonize the intestine to improve the intestinal microbial flora and improve the development environment of the disease, regulate the balance of pro-inflammatory factors and anti-inflammatory factors, so as to improve ulcerative colitis, and won the Chinese invention patent No. ZL 2021 1 1566079.0.
Clinical Trial 1:
A total of 100 patients with ulcerative colitis whose main symptoms were fecal mucus and pus, abdominal pain, increased stool frequency or loose stools, including 48 males and 52 females, were enrolled. They were divided into control group and experimental group, with 50 cases in each group. Experimental group: 25 males, 25 females, age 20 ~ 65 years, average age 45.8 years, disease duration 1~10 years, average disease duration 4.8 years, 42 cases with fecal mucus, pus and blood, 35 cases of abdominal pain, 50 cases of increased stool frequency, 47 cases of loose stool.
The experimental group was treated with mesalazine (0.4 g) 2 tablets 3 times a day, and Lactobacillus reuteri JYLB291 once a day at a dose of 1×108 cfu/kg body weight.
The treatment time was 30 days, and it can be seen that the treatment effect of the four most typical symptoms (stool mucus and blood, abdominal pain, increased stool frequency, loose stool) was significantly improved after adjuvant treatment with Lactobacillus reuteri JYLB291 1×108 cfu/kg bw/day, and the effective rate was up to 95.7%.
Each bag of Lactobacillus reuteri JYLB291 added to Huojun No. 1 is not less than 10 billion cfu, which is much higher than the clinical control test dose of 1×108 cfu/kg body weight. In addition, each bag of Huojun No. 1 also adds no less than 10 billion cfu of the star patented strain Lactobacillus casei L.Casei21, which can enter the intestine through the digestive tract, inhibit pathogenic bacteria, colonize the intestine, maintain the balance of environmental flora, improve diarrhea symptoms, and reduce the risk of diarrhea recurrence, and won the China invention patent No. ZL 2021 1 0242478.5.
Clinical Trial 2:
A total of 100 patients with abdominal pain, diarrhea, frequent bowel movements, and warmth in the limbs were selected and divided into control group and experimental group, with 50 people in each group, and the trial lasted for 30 days. During the trial, each patient's living and eating habits remained unchanged, and they all took trimethyl maleate pudding tablets once a day according to the doctor's instructions, and the experimental group took an additional 15 billion Lactobacillus casei L after taking trimethyl maleate tablets for 2 hours. Casei21 once. After 30 days, the efficacy was observed and statistics, and the statistical results are shown in the following table. Casei21 and its products have a clear positive therapeutic effect on patients with diarrhea, with an overall response rate of up to 92%.
According to the results of the above clinical trials, it is inferred that because probiotics regulate the stomach and intestines, we must first fight against harmful bacteria, and after a competitive period, a period of stalemate, a reversal period, and a dominant period, we can fully exert its health effects, and after 3 to 6 months of combined medication, ulcerative colitis is expected to embark on the road of comprehensive recovery.
Because ulcerative colitis is related to autoimmune factors, it is difficult to heal and is prone to cancer. Because free radicals attack normal immune cells, making them "abnormal", these "abnormal" immune cells blindly attack the intestinal mucosal cells, causing inflammation and even forming cancer cells. The theory of free radicals believes that free radicals are the root of all evils in the human body towards aging, illness, tumors, and death, and are the culprits of autoimmune diseases such as ulcerative colitis, Crohn, and irritable bowel syndrome.
In order to remove excess free radicals from the human body, Huojun No. 1 adds no less than 5 billion star patented strains of Bifidobacterium longum JBLC-141 per bag, which can remove excess free radicals in the body, prevent the loss of free radicals to the body's cells, and also play a certain protective role in cell oxidative damage, and relieve the body's fatigue, won the Chinese invention patent No. 202110227019.X, which is very important for the prevention of malignant transformation and recovery of ulcerative colitis. (Refer to "Patent Details")
It is reported that Huojun No. 1 has landed on the official flagship store of Jingdong Huojun No. 1 for external sales, with "high-end customized enteritis patent formula, five invention patents, pure raw powder without additives and no allergies, the real content of six live bacteria exceeds 50 billion, super active and non-dependent, probiotics special workshop production pollution-free, one company one product ingenuity service" and other seven advantages, to win user feedback satisfaction is more than expected, for ulcerative colitis patients to light a new lamp of hope.
Disclaimer:
The content of the articles published or reproduced by this platform and indicated from other sources is only for exchange and learning reference, and does not mean that it agrees with its views or confirms the authenticity of its content, and is not used as any investment basis.